These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10325833)

  • 21. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J; Bagge L; Saldeen T; Thelin S
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
    Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequestration of propofol in an extracorporeal circuit.
    Tarr TJ; Kent AP
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):75. PubMed ID: 2521009
    [No Abstract]   [Full Text] [Related]  

  • 27. Modified surface coatings and their effect on drug adsorption within the extracorporeal life support circuit.
    Preston TJ; Ratliff TM; Gomez D; Olshove VE; Nicol KK; Sargel CL; Chicoine LG
    J Extra Corpor Technol; 2010 Sep; 42(3):199-202. PubMed ID: 21114222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
    Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
    J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of propofol levels in isolated cardiopulmonary bypass circuit.
    Su HB; Tseng CC; Jenn CT; Chang CL; Huang JD
    Acta Anaesthesiol Sin; 1996 Mar; 34(1):17-20. PubMed ID: 9084514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
    Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
    Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
    Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of platelet reactivity toward annuloplasty devices treated with heparin coating: studies under flow conditions.
    Tonda R; Galán AM; Pino M; Hernández MR; Ayats C; Pomar JL; Ordinas A; Escolar G
    J Biomed Mater Res A; 2005 Oct; 75(1):192-8. PubMed ID: 16044416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery.
    Hosoyama K; Ito K; Kawamoto S; Kumagai K; Akiyama M; Adachi O; Kawatsu S; Sasaki K; Suzuki M; Sugawara Y; Shimizu Y; Saiki Y
    J Artif Organs; 2016 Sep; 19(3):233-40. PubMed ID: 26909493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers.
    Annich GM; Meinhardt JP; Mowery KA; Ashton BA; Merz SI; Hirschl RB; Meyerhoff ME; Bartlett RH
    Crit Care Med; 2000 Apr; 28(4):915-20. PubMed ID: 10809259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracorporeal circulation, hemocompatibility, and biomaterials.
    Janvier G; Baquey C; Roth C; Benillan N; Bélisle S; Hardy JF
    Ann Thorac Surg; 1996 Dec; 62(6):1926-34. PubMed ID: 8957436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations.
    Giomarelli P; Naldini A; Biagioli B; Borrelli E
    Int J Artif Organs; 2000 Apr; 23(4):250-5. PubMed ID: 10832659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
    te Velthuis H; Baufreton C; Jansen PG; Thijs CM; Hack CE; Sturk A; Wildevuur CR; Loisance DY
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.